Bio-Path Holdings, Inc.
BPTH· OTC
BPTHBio-Path Holdings, Inc.
Filed Apr 2, 2018 · 10-K · 92 days after period end · 0001144204-18-018611
derived · Computed from the longer spans the company filed.
| Metric | Q4 2017dderived from reported figures | Q4 2016 | Q4 2015 | Q4 2014 |
|---|---|---|---|---|
| Revenue | $37.00K | $13.00K | $0.00 | $0.00 |
| Net Income | -$2.17M | -$1.37M | -$1.46M | -$1.60M |
| EPS Diluted | — | -$0.01 | -$0.02 | -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
ended Dec 31, 2017 · filed Apr 2, 2018 · 92 d after period end
